During the past decade, Kreiskrankenhaus Gummersbach GmbH conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kreiskrankenhaus Gummersbach GmbH" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials, followed by "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 2 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored, "Johannes Gutenberg University Mainz" with 1 trials sponsored and "MEDA Pharma GmbH & Co. KG" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kreiskrankenhaus Gummersbach GmbH" #1 collaborator was "Clinipace Worldwide" with 1 trials as a collaborator, "Deutsche Krebshilfe e.V., Bonn (Germany)" with 1 trials as a collaborator, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Kreiskrankenhaus Gummersbach GmbH" are "Lymphoma" (2 trials), "Brain and Central Nervous System Tumors" (1 trials), "CD20+ Aggressive B-Cell Lymphoma" (1 trials), "Long-term Effects Secondary to Cancer Therapy in Children" (1 trials) and "Lymph Node Metastasis" (1 trials). Many other conditions were trialed in "Kreiskrankenhaus Gummersbach GmbH" in a lesser frequency.

Most popular intervention types in "Kreiskrankenhaus Gummersbach GmbH" are "Drug" (7 trials), "Radiation" (4 trials), "Biological" (3 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials), "radiation therapy" (3 trials), "vincristine sulfate" (3 trials) and "conventional surgery" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kreiskrankenhaus Gummersbach GmbH" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Kreiskrankenhaus Gummersbach GmbH". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Kreiskrankenhaus Gummersbach GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kreiskrankenhaus Gummersbach GmbH, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".